Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data

L Lippenszky, KF Mittendorf, Z Kiss… - JCO Clinical Cancer …, 2024 - ascopubs.org
PURPOSE Although immune checkpoint inhibitors (ICIs) have improved outcomes in certain
patients with cancer, they can also cause life-threatening immunotoxicities. Predicting …

Network-based machine learning approach to predict immunotherapy response in cancer patients

JH Kong, D Ha, J Lee, I Kim, M Park, SH Im… - Nature …, 2022 - nature.com
Immune checkpoint inhibitors (ICIs) have substantially improved the survival of cancer
patients over the past several years. However, only a minority of patients respond to ICI …

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

S Iivanainen, J Ekstrom, H Virtanen, VV Kataja… - BMC Medical Informatics …, 2021 - Springer
Abstract Background Immune-checkpoint inhibitors (ICIs) have introduced novel immune-
related adverse events (irAEs), arising from various organ systems without strong timely …

Biology-aware mutation-based deep learning for outcome prediction of cancer immunotherapy with immune checkpoint inhibitors

J Liu, MT Islam, S Sang, L Qiu, L Xing - NPJ Precision Oncology, 2023 - nature.com
The response rate of cancer immune checkpoint inhibitors (ICI) varies among patients,
making it challenging to pre-determine whether a particular patient will respond to …

A pan-cancer approach to predict responsiveness to immune checkpoint inhibitors by machine learning

M Polano, M Chierici, M Dal Bo, D Gentilini, F Di Cintio… - Cancers, 2019 - mdpi.com
Immunotherapy by using immune checkpoint inhibitors (ICI) has dramatically improved the
treatment options in various cancers, increasing survival rates for treated patients …

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

A Prelaj, V Miskovic, M Zanitti, F Trovo, C Genova… - Annals of …, 2023 - Elsevier
Background The widespread use of Immune checkpoint-inhibitors (ICI) has revolutionised
treatment of multiple cancer types. However, selecting patients who may benefit from ICI …

A deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: An ORIEN …

P Ghasemi Saghand, I El Naqa, AC Tan, M Xie, D Dai… - 2022 - ascopubs.org
2619 Background: Immune checkpoint inhibitors (ICIs) have made significant improvements
in the treatment of cancer patients (pts), but many continue to experience primary or …

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

D Chowell, SK Yoo, C Valero, A Pastore… - Nature …, 2022 - nature.com
Only a fraction of patients with cancer respond to immune checkpoint blockade (ICB)
treatment, but current decision-making procedures have limited accuracy. In this study, we …

Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint …

N Zhao, A Jiang, X Shang, F Zhao, R Wang… - Journal of …, 2023 - journals.lww.com
Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic landscape of cancer
therapy. This study aimed to develop novel risk classifiers to predict the risk of immune …

[HTML][HTML] Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

SP Heilbroner, R Few, TG Neilan… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Treatment with immune checkpoint inhibitors (ICIs) has been associated with
an increased rate of cardiac events. There are limited data on the risk factors that predict …